Bank of Montreal’s Capricor Therapeutics CAPR Stock Holding History

Bank of Montreal’s Portfolio CAPR Stock Details CAPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-1,349	Closed	-$68K	–	3988
2015 Q2	$68K	Buy	+1,349	New	+$84.7K	﹤0.01%	2894

Other funds holding CAPR

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baird Financial Group Milwaukee, Wisconsin $64B AUM 22.64% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

CFN

Cordasco Financial Network Naples, Florida $138M AUM 10.5% 1-Year Est. Return

Bank of Montreal's CAPR Position: Q3 2015 in Review

Bank of Montreal sold out of Capricor Therapeutics (CAPR) in Q3 2015, closing a stake of 1,349 shares — an estimated $68K sold.

Bank of Montreal first reported a position in CAPR in Q2 2015 and held it in 1 quarter. The position peaked at $68K in Q2 2015. 15 funds tracked by Wall St. Rank hold CAPR as of Q3 2015.

Bank of Montreal reported no remaining Capricor Therapeutics position as of Q3 2015 after selling out during the quarter.
Bank of Montreal sold 1,349 Capricor Therapeutics shares in Q3 2015, an estimated $68K.
Bank of Montreal first reported a position in Capricor Therapeutics in Q2 2015 and held it in 1 quarter.
Bank of Montreal's Capricor Therapeutics position peaked at $68K in Q2 2015.
15 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q3 2015.

Based on Bank of Montreal's 13F filing for Q3 2015, filed 12 Nov 2015.